INFORMATION FOR
News
Edward J. Miller, MD, PhD and Parul Gandhi, MD, welcome eleven outstanding trainees.
Connecticut Magazine's 2023 ‘Top Doctors’ list includes 16 faculty in the Section of Cardiovascular Medicine.
El Dr. Carlos Mena-Hurtado recibió un premio rally del centro de coordinación clínica por el liderazgo excepcional en el ensayo CREST-2.
Carlos Mena-Hurtado, MD, was appointed to serve on the Society for Vascular Surgery Patient Safety Organization (SVS PSO) Governing Council.
Carlos Mena-Hurtado, MD, received a Clinical Coordinating Center Rally award for outstanding leadership in the CREST-2 trial.
John Spertus, MD, MPH, an expert on the measurement of quality of care and health status in cardiovascular disease, will speak at the virtual VAMOS Research Meeting on Tuesday, April 18.
The Council on Peripheral Vascular Disease expert perspective provides interventions to improve PAD outcomes and patient satisfaction.
Half of Medicare patients who underwent a procedure for symptom relief for peripheral vascular disease did not receive the recommended medical therapy for long-term cardiovascular risk management.
Yale medical students develop clinical and research skills at Yale’s Vascular Medicine OutcomeS (VAMOS) lab.
Bypass surgery in artiries leading to the legs was associated with a lower risk of cardiac events among patients with peripheral arterial disease who are candidates for two types of revascularization therapy, new research suggests.
A meta-analysis of 119,123 patients with peripheral artery disease (PAD) demonstrates that depressive symptoms were associated with a 24 % increased risk of all-cause mortality.
The American Heart Association (AHA) released a scientific statement to advance the science and practice of PAD treatment.
The Vascular Medicine Outcomes (VAMOS) Program at Yale will present twelve abstracts at this year’s American Heart Association (AHA) Scientific Sessions in Chicago, IL.
Safety and efficacy after using VASCADE closure device system was comparable with the standard treatment option for patients with severe peripheral artery disease.
Kim G. Smolderen, PhD, has received a R21 National Institutes of Health (NIH) National Center for Complementary and Integrative Health grant,
Adults who share a Hispanic background and who get hospitalized for symptoms of peripheral artery disease (PAD) are more likely to only receive care at later stages of their disease, and get their treatment through the emergency department instead of early stage disease care, elective care as compared with non-Hispanic white patients.
Kim G. Smolderen, PhD, has been accepted to the Society of Behavioral Medicine Leadership Institute.
Late-Breaking Basic Science submissions for the AHA Scientific Sessions close August 23.
Jonathan Hanna, MD, has been selected as a finalist for the American Heart Association’s Jay D. Coffman Early Career Investigator Award.
The study suggests that implementing a nationwide screening effort and other preventive strategies could identify important opportunities to further address the risk of chronic disease among older adults.